Distinct domain switching in Nd0.05Ce0.95CoIn5 at low and high fields

Código QR

Distinct domain switching in Nd0.05Ce0.95CoIn5 at low and high fields

Abstract Nd0.05Ce0.95CoIn5 features a magnetic field-driven quantum phase transition that separates two antiferromagnetic phases with an identical magnetic structure inside the superconducting condensate. Using neutron diffraction we demonstrate that the population of the two magnetic domains in the...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	D. G. Mazzone, R. Yadav, M. Bartkowiak, J. L. Gavilano, S. Raymond, E. Ressouche, G. Lapertot, M. Kenzelmann
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2018
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/844fe8cc5bf84e9b8f3d95b2d4fd04ca
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

One-Pot Synthesis of Ni<sub>0.05</sub>Ce<sub>0.95</sub>O<sub>2−δ</sub> Catalysts with Nanocubes and Nanorods Morphology for CO<sub>2</sub> Methanation Reaction and in Operando DRIFT Analysis of Intermediate Species
por: Igor Luisetto, et al.
Publicado: (2021)

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
por: Inoue K, et al.
Publicado: (2012)

Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
por: Kanamoto T, et al.
Publicado: (2012)

Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
por: Mizoguchi T, et al.
Publicado: (2017)

The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery
por: Turan-Vural E, et al.
Publicado: (2011)

Evolution of two bulk-superconducting phases in Sr0.5 RE 0.5FBiS2 (RE: La, Ce, Pr, Nd, Sm) by external hydrostatic pressure effect
por: Aichi Yamashita, et al.
Publicado: (2020)

Facile synthesis of g-C3N4(0.94)/CeO2(0.05)/Fe3O4(0.01) nanosheets for DFT supported visible photocatalysis of 2-Chlorophenol
por: Jamshaid Rashid, et al.
Publicado: (2019)

Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
por: Yelda Buyru &Ouml;zkurt, et al.
Publicado: (2009)

A study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension
por: Douglas J Rhee, et al.
Publicado: (2008)

Green synthesis, characterization and anti-cancer capability of Co0.5Ni0.5Nd0.02Fe1.98O4 nanocomposites
por: M.A. Almessiere, et al.
Publicado: (2022)

Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months
por: Inoue K, et al.
Publicado: (2014)

The Bayes Factor, a Suitable Complement beyond Values of p<0.05 in Nursing Research and Education
por: Cristian Antony Ramos-Vera
Publicado: (2021)

Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye
por: Deveney T, et al.
Publicado: (2018)

LiNi0.8Co0.15Al0.05O2: Enhanced Electrochemical Performance From Reduced Cationic Disordering in Li Slab
por: Peng Xiao, et al.
Publicado: (2017)

Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies
por: Arthur B Epstein, et al.
Publicado: (2009)

Impacto sobre el tamaño de las muestras en estudios nacionales si cambiara el nivel de significación estadística de α= 0,05 a α = 0,005
por: Villarroel del Pino,Luis
Publicado: (2021)

Crystal structure, thermal and electrotransport properties of NdBa1–xSrxFeCo0.5Cu0.5O5+δ (0.02 ≤ x ≤ 0.20) solid solutions
por: A. I. Klyndyuk, et al.
Publicado: (2021)

Difluprednate 0.05% versus Prednisolone Acetate Post-Phacoemulsification for Inflammation and Pain: An Efficacy and Safety Clinical Trial
por: Palacio-Pastrana C, et al.
Publicado: (2020)

Efficacy of Topical Finasteride 0.5% vs 17α-Estradiol 0.05% in the Treatment of Postmenopausal Female Pattern Hair Loss: A Retrospective, Single-Blind Study of 119 Patients
por: Alfredo Rossi, et al.
Publicado: (2020)

Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination
por: Inoue K, et al.
Publicado: (2012)

Impact of dielectric properties on ionic conductivity of Ce0.9Sm0.1O1.95 via defect interaction
por: Sk. Anirban, et al.
Publicado: (2021)

Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®)
por: Katelin Quantz, et al.
Publicado: (2021)

Efficacy and safety of 0.5% levobupivacaine versus 0.5% bupivacaine for peribulbar anesthesia
por: Pacella E, et al.
Publicado: (2013)

Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease
por: Burade V, et al.
Publicado: (2020)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
por: Inoue K, et al.
Publicado: (2015)

A retrospective analysis of intraocular pressure changes after cataract surgery with the use of prednisolone acetate 1% versus difluprednate 0.05%
por: Kusne Y, et al.
Publicado: (2016)

Li(V0.5Ti0.5)S2 as a 1 V lithium intercalation electrode
por: Steve J. Clark, et al.
Publicado: (2016)

Influence of LRE (Ce, Y, and La) on microstructure and magnetic properties of (Nd0.8LRE0.2)–Fe–B hot-deformed magnets
por: Y. Milov, et al.
Publicado: (2021)

Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature
por: Rhee MK, et al.
Publicado: (2017)

Dose uniformity of topical corticosteroid preparations: difluprednate ophthalmic emulsion 0.05% versus branded and generic prednisolone acetate ophthalmic suspension 1%
por: William Stringer, et al.
Publicado: (2010)

Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy
por: Schnober D, et al.
Publicado: (2015)

Preparation and characterization of a new graphite superconductor: Ca0.5Sr0.5C6
por: Saki Nishiyama, et al.
Publicado: (2017)

Light-induced enhancement of superconductivity in iron-based superconductor FeSe0.5Te0.5
por: Kazuki Isoyama, et al.
Publicado: (2021)

Magnetic breakdown in 2D hole system at GaAs/Al0.5Ga0.5As heterointerface
por: Minina, N., et al.
Publicado: (2005)

Photoconductivity in p-GaAs/Al0.5Ga0.5As and deep donor like states at heterointerface
por: Bogdanov, E., et al.
Publicado: (2005)

The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye
por: Stonecipher KG, et al.
Publicado: (2016)

Difluprednate ophthalmic emulsion 0.05% (Durezol&reg;) administered two times daily for managing ocular inflammation and pain following cataract surgery
por: Stephen Smith, et al.
Publicado: (2010)

A randomized crossover study comparing tafluprost 0.005% with travoprost 0.004% in patients with normal-tension glaucoma
por: Mizoguchi T, et al.
Publicado: (2012)

Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension
por: Baiza-Dur&aacute;n LM, et al.
Publicado: (2012)

Thick Film Ni0.5Mn0.5−xSnx Heusler Alloys by Multi-layer Electrochemical Deposition
por: Yijia Zhang, et al.
Publicado: (2018)